A natural compound called phloretin, found in apples, protected kidney function and reduced scarring in laboratory and animal studies by targeting a protein called WNT2B. According to Gram Research analysis, phloretin also fixed damaged mitochondria and reduced inflammation in kidney cells and mice with kidney injury. However, human studies are needed before this compound could become a treatment for people with kidney disease.
Researchers discovered that phloretin, a natural compound found in apples, may help prevent kidney scarring (fibrosis), a major cause of kidney disease. In laboratory and animal studies, phloretin worked by turning off a specific protein called WNT2B that triggers kidney damage. The compound also fixed broken mitochondria (the energy centers of cells) and reduced inflammation. While these results are promising, human studies are still needed to confirm whether eating apples or taking phloretin supplements could actually help people with kidney problems.
Key Statistics
A 2026 laboratory study found that phloretin reduced kidney scarring markers and preserved kidney function in mice with folic acid-induced kidney injury by targeting the WNT2B protein.
Research published in 2026 showed that phloretin improved mitochondrial quality control in kidney cells by reactivating a cellular cleanup process called PINK1/Parkin-mediated mitophagy.
A 2026 study demonstrated that genetically blocking WNT2B produced the same kidney-protective effects as phloretin treatment, confirming WNT2B as the critical target for the compound’s anti-fibrotic action.
The Quick Take
- What they studied: Whether a natural apple compound called phloretin could stop kidney scarring by targeting a specific protein involved in kidney damage
- Who participated: Laboratory studies using kidney cells and mice with kidney injury from folic acid exposure; no human participants in this research
- Key finding: Phloretin reduced kidney scarring and preserved kidney function by turning off the WNT2B protein and fixing damaged mitochondria in both cell and animal models
- What it means for you: This research suggests phloretin might one day help treat kidney disease, but it’s still in early stages. Don’t expect apple-based treatments yet, as human studies are needed first. Talk to your doctor before trying any supplements based on this research.
The Research Details
This was a laboratory and animal study published in 2026 that tested phloretin, a natural compound found in apples and other plants. The researchers used two main approaches: first, they grew kidney cells in dishes and treated them with phloretin to see what happened; second, they gave phloretin to mice with kidney damage to test whether it worked in living animals. They measured various markers of kidney health, scarring, and inflammation to track the effects.
The study focused on understanding how phloretin works at the molecular level. The researchers identified that phloretin targets a specific protein called WNT2B, which appears to be a key driver of kidney scarring. They also examined how phloretin affects mitochondria, the tiny structures inside cells that produce energy. When mitochondria break down, they can trigger kidney damage, so the researchers tested whether phloretin could fix this problem.
To confirm their findings, the researchers also used genetic techniques to directly block WNT2B in cells and animals. When they did this, the protective effects matched what they saw with phloretin treatment, suggesting that WNT2B is indeed the main target responsible for phloretin’s benefits.
This research approach is important because it identifies a specific molecular target (WNT2B) that could be used to develop new kidney disease treatments. By understanding exactly how phloretin works, scientists can design better drugs or determine whether natural compounds like phloretin could be useful. The combination of cell studies and animal models provides stronger evidence than either approach alone, though human studies are still needed.
This study was published in a peer-reviewed journal focused on plant-based medicines, which is appropriate for this topic. The research used multiple complementary methods (cell cultures, animal models, and genetic techniques) to test the same hypothesis from different angles, which strengthens the findings. However, the study did not include human participants, so results cannot yet be directly applied to people. The exact sample sizes for cell and animal experiments were not specified in the abstract, which limits our ability to fully assess the study’s power.
What the Results Show
In kidney cells treated with phloretin, the compound successfully reduced the expression of WNT2B protein. This reduction led to decreased activation of a harmful pathway called beta-catenin signaling, which normally drives kidney scarring. The cells also showed improved mitochondrial function, meaning their energy-producing structures were working better. Markers of kidney cell damage decreased, and the cells maintained their normal structure and function better than untreated cells.
In mice with kidney injury, phloretin treatment preserved kidney function and reduced scarring compared to untreated animals. The treated mice showed less expression of proteins associated with fibrosis (scarring) and maintained better kidney structure. Inflammation markers were also reduced in the treated animals, suggesting phloretin reduced the inflammatory response that contributes to kidney damage.
When the researchers directly blocked WNT2B using genetic techniques, the protective effects were similar to what they observed with phloretin treatment. This finding strongly suggests that WNT2B is the key target through which phloretin exerts its protective effects. The compound also appeared to improve mitochondrial quality control, a process called mitophagy, which helps cells remove damaged mitochondria.
The study found that phloretin reduced inflammation through multiple pathways, including the TLR4/MyD88/NLRP3 pathway, which is known to drive kidney inflammation. The compound also improved the balance between mitochondrial fission (splitting) and fusion (joining), helping cells maintain healthy mitochondria. These secondary effects suggest phloretin works through multiple mechanisms, not just one pathway, which could make it more effective than drugs targeting a single process.
Previous research has shown that Wnt signaling and mitochondrial dysfunction both contribute to kidney scarring, but the specific connection between these processes was unclear. This study identifies WNT2B as the missing link. The findings also align with growing evidence that natural compounds from plants can have protective effects on kidney health, though most such compounds have not been thoroughly tested in humans. The focus on mitochondrial quality control (mitophagy) reflects recent advances in understanding how cells protect themselves from damage.
The most significant limitation is that this research was conducted in laboratory dishes and mice, not in humans. Results in animals often do not translate directly to people due to differences in metabolism and physiology. The study did not specify exact sample sizes for the cell and animal experiments, making it difficult to assess statistical power. The research also did not test different doses of phloretin or compare it to existing kidney disease treatments. Additionally, the study did not examine potential side effects or toxicity of phloretin at therapeutic doses. Long-term effects were not studied, so we don’t know whether phloretin would remain effective over months or years of treatment.
The Bottom Line
Based on this early-stage research, phloretin cannot yet be recommended as a kidney disease treatment. The findings are promising enough to warrant human clinical trials, but these have not yet been conducted. People with kidney disease should continue following their doctor’s treatment recommendations and not attempt to self-treat with apple-based products or phloretin supplements based on this research alone. Confidence level: Low (preliminary research only).
People with chronic kidney disease or at risk for kidney disease should be aware of this research as a potential future treatment option. Researchers studying kidney disease and natural compound therapeutics should find this work particularly relevant. People interested in plant-based medicine may find this encouraging, though it’s too early to act on. People should NOT attempt to treat kidney disease with apples or phloretin supplements without medical supervision.
If phloretin moves forward to human clinical trials, it would typically take 5 to 10 years before it could potentially become an approved treatment. Early-phase trials would assess safety and dosage, followed by larger trials testing effectiveness. Even if successful, regulatory approval would be required before widespread use.
Frequently Asked Questions
Can eating apples help prevent kidney disease based on this research?
Not yet. While phloretin from apples showed promise in laboratory and animal studies, human research is needed first. Eating apples is healthy, but don’t expect them to treat kidney disease without medical supervision and further evidence.
What is phloretin and where is it found naturally?
Phloretin is a natural compound called a flavonoid found mainly in apples, apple peels, and some other plants. In this 2026 study, it protected kidney cells and improved kidney function in mice by targeting a specific protein involved in kidney scarring.
How does phloretin protect kidneys according to this study?
Phloretin works by turning off a protein called WNT2B that drives kidney scarring. It also fixes damaged mitochondria (cell energy centers) and reduces inflammation, addressing multiple pathways that contribute to kidney damage.
Is phloretin safe for people with kidney disease to take?
Safety in humans has not been tested in this research. Anyone with kidney disease considering phloretin supplements should consult their doctor first, as the appropriate dose and potential interactions are unknown.
When might phloretin become available as a kidney disease treatment?
If human clinical trials begin soon, phloretin could potentially become an approved treatment in 5 to 10 years, assuming it proves safe and effective. Currently, it remains a laboratory discovery requiring further research.
Want to Apply This Research?
- Users with kidney disease could track kidney function markers (creatinine levels, glomerular filtration rate) monthly through their healthcare provider and log these in the app alongside any dietary changes or supplement use, creating a personal record to discuss with their doctor.
- Users interested in kidney health could log daily apple consumption and other plant-based foods rich in flavonoids, while also tracking kidney health markers provided by their healthcare provider, creating awareness of dietary patterns without making unsupported medical claims.
- Establish a quarterly check-in system where users record kidney function test results from their doctor visits and note any changes in kidney health symptoms, allowing them to see trends over time and share data with their healthcare provider for informed discussions about emerging treatments.
This research is preliminary and was conducted in laboratory cells and animals only. Phloretin has not been tested in humans for kidney disease treatment. Do not attempt to treat kidney disease with apples, apple supplements, or phloretin without consulting your doctor. If you have kidney disease, continue following your healthcare provider’s treatment recommendations. This article is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional before starting any new supplement or treatment, especially if you have existing kidney disease or take medications that affect kidney function.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.